Nucleic acid extraction 32-well Nucleic Acid Extractor

Features

-Easy operation

13-inch color touch screen and friendly operation interface can easily set program parameters.

-Stable and efficient

The whole process is automated to avoid differences and errors caused by manual operations and improve efficiency.

-Avoid contamination

The instrument has a built-in UV disinfection function to reduce cross-contamination.

-Advanced vibration technology

The fastest stirring speed can reach 10HZ (10 times up and down in 1 second), effectively mixing viscous samples (such as blood, feces, etc.)

-Multiple heating modes

Multiple heating plates can be individually temperature controlled to provide high precision temperature for lysis and elution.

-Safe and reliable

After the safety door is opened, the instrument automatically suspends operation. When it is confirmed that the safety door is closed, the instrument can automatically continue to run the program to improve the safety of use.

-Self-check function

The program will automatically check the position between the magnetic rod, the magnetic rod sleeve and the deep hole plate before each running of the program to prevent the occurrence of leakage and misplacement, and effectively protect the normal operation of the program.

Product pictures:

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.